Muhammad Osama Mazhar, Shehrood Naeem, Seerat Saeed
Objective: This study was undertaken with the objective to evaluate the response and effect of intravenous iron sucrose given to patient in antenatal and postnatal period with moderate iron deficiency anemia. Methods: This was a cross-sectional prospective study conducted from August to November 2019 in the department of obstetrics and gynecology Nishtar Hospital Multan. Antenatal and postnatal patients with hemoglobin between 5-9 gm% with diagnosed iron deficiency anemia were included in the study. The aim was to bring her hemoglobin level to 11gm%. Results: A total of 35 patients were included in study. Iron sucrose therapy was found effective in achieving target hemoglobin of 11gm/dl in 80% of patients showing that intravenous iron sucrose significantly (P< 0.001) increase hemoglobin level within two weeks of therapy without any major adverse effects. Conclusion: Intravenous iron therapy was effective in increasing hemoglobin, serum ferritin and other hematological parameters in antenatal and postnatal patients with anemia with minimal risk of maternal complication during pregnancy and postpartum and its adverse effect to fetus. Keywords: iron deficiency anemia; intravenous iron; pregnancy.